Keyphrases
High-risk Human Papillomavirus (HR-HPV)
76%
Cervical Cancer Screening
67%
Denmark
61%
Human Papillomavirus Testing
53%
SurePath
32%
Cervical Cancer
31%
Colorectal Cancer
26%
HPV Testing
25%
Papillomavirus Infections
21%
Diabetic Nephropathy
20%
Tumor
19%
HPV16
19%
Confidence Interval
19%
Hybrid Capture
18%
Biological Stain Commission
16%
Human Papillomavirus Prevalence
16%
People Living with HIV (PLHIV)
16%
Human Papillomavirus Genotypes
15%
Clinical Performance
15%
Pathologist
14%
Cervical Intraepithelial Neoplasia
14%
Genotype
14%
Self-sampling
14%
Clinical Validation
13%
Onclarity
12%
Human Papillomavirus Vaccine
12%
Borderline Tumor
12%
Aptima
11%
Non-alcoholic Fatty Liver Disease (NAFLD)
11%
Cobas
11%
Non-attenders
11%
High-risk HPV
11%
Human Papillomavirus Types
11%
Liquid-based Cytology
10%
Cervical Samples
10%
Atypical Squamous Cells of Undetermined Significance (ASC-US)
10%
Population-based Study
9%
CIN2+
9%
Abnormal Cytology
9%
HPV Genotyping
9%
Cervical Intraepithelial Neoplasia Grade 3
9%
High-grade Cervical Intraepithelial Neoplasia
9%
Histology
9%
FAM19A4
9%
MiR-124
9%
Lynch Syndrome
9%
Risk Factors
8%
Immunohistochemical Staining
8%
Atypical Proliferative Serous Tumor
8%
Immunohistochemistry
8%
Ulcerative Colitis
7%
Copenhagen
7%
Invasive Cervical Cancer
7%
Polyps
7%
High Risk
7%
Analytical Performance
7%
Danish Population
7%
Nonalcoholic Steatohepatitis
7%
Syncytin-1
7%
Type 1 Diabetic Patient
7%
Breast Cancer
7%
Hereditary Colorectal Cancer Syndromes
7%
HPV Positive
7%
Carcinoma
6%
ThinPrep
6%
HIV Patients
6%
Lymph Node
6%
Human Papillomavirus DNA
6%
Type Distribution
6%
Sessile Serrated Adenoma
6%
Older Women
5%
CIN3+
5%
Cytological Samples
5%
Population-based
5%
Colorectal Carcinoma
5%
Enzyme-linked Immunosorbent Assay (ELISA)
5%
Cutaneous T-cell Lymphoma
5%
Abnormal Cervical Cytology
5%
International Affairs
5%
Cervical Cancer Incidence
5%
Lymphoma
5%
Sample Splitting
5%
Elderly Women
5%
Cancer Cases
5%
Routine Screening
5%
Methylation
5%
Kidney Transplant Recipients
5%
Lymphocytic Colitis
5%
Renal Transplant Recipients
5%
Isradipine
5%
Multiple Persons
5%
Idiopathic Intracranial Hypertension
5%
VALGENT
5%
Hyperplastic Polyp
5%
Age Groups
5%
HPV2
5%
Cancer Cells
5%
Cervical Intraepithelial Neoplasia Grade 2
5%
Testing Framework
5%
Genotype Distribution
5%
Medicine and Dentistry
Wart Virus
100%
Neoplasm
49%
Cytotechnology
45%
Cervical Cancer Screening
37%
Prevalence
32%
Cervical Cancer
31%
Cervical Screening
28%
Diagnosis
27%
Cervical Intraepithelial Neoplasia
26%
Genotype
24%
Papillomavirus Infection
23%
Screening
22%
Human Immunodeficiency Virus
19%
Biopsy
17%
Colorectal Cancer
17%
In Vitro
17%
Malignant Neoplasm
16%
Polymerase Chain Reaction
13%
Disease
12%
Pathologist
12%
Human Papillomavirus Type 16
12%
Regulatory Affairs
12%
Cancer Cell
11%
Kidney Graft
10%
Diabetic Nephropathy
10%
Breast Cancer
10%
Immunohistochemistry
9%
Methylation
9%
Diagnostic Test
9%
Population
9%
Laboratory Test
9%
Hereditary Nonpolyposis Colorectal Cancer
9%
P16
9%
Liquid-Based Cytology
9%
Carcinoma
8%
Lymph Node
8%
Clinician
8%
Enzyme Immunoassay
8%
Morphology
8%
Insulin Dependent Diabetes Mellitus
7%
Triage
7%
Uterine Cervix Cytology
7%
Squamous Cell
7%
Colorectal Carcinoma
7%
Nonalcoholic Fatty Liver
7%
Ulcerative Colitis
7%
Liver Cirrhosis
7%
Magnetic Resonance Imaging
6%
Sensitivity and Specificity
6%
Polyp
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Haematoxylin
6%
Infection
6%
Implant
6%
Colposcopy
6%
Systematic Review
5%
Metastatic Carcinoma
5%
Reproducibility
5%
Rectum Cancer
5%
Rectum Carcinoma
5%
Chemoradiotherapy
5%
DNA Mismatch Repair
5%
Childbirth
5%
Clinical Study
5%
Cutaneous T Cell Lymphoma
5%
Lymphocytic Colitis
5%
Next Generation Sequencing
5%
Colon Cancer
5%
Fatty Liver
5%
Liver Biopsy
5%